atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference | Psychedelic Invest

NEW YORK and BERLIN, May 23, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the appointment of Scott Braunstein, M.D., and Laurent Fischer, M.D., as independent directors of atai’s supervisory board (“Board”) subject to applicable legal requirements. Scott…

Medable & Pluto Health Partner to Increase Patient Access to Clinical Trials

What You Should Know: – Medable Inc., a technology provider for modern clinical trials forms an enterprise partnership with Pluto Health, a smart care coordination

October 4, 2023

Clonazepam Recall Expands; Lipid Depression Screening; Period Pain and Depression

The FDA broadcast Endo’s expanded recall of clonazepam tablets, used for panic disorder among other conditions, due to potential product carton strength mislabeling. After controlling

November 28, 2024

CAR-T therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies

Researchers were perplexed when the Food and Drug Administration announced it was investigating whether CAR-T therapy, one of the most effective treatments for blood cancers,

July 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.